Hence, authors showed that lncRNA MIAT also plays an important role in microvascular dysfunction induced by DM and MIAT/miR-150/VEGF axis may represent a further pharmacological target for treating neurovascular-related disorders [19] (Figure 2, Table 2). This evidence concerns the gene VEGFA and diabetes mellitus.